Prevalence and characteristics of TERT and TERC mutations in suspected genetic pulmonary fibrosis

Raphael Borie, Laure Tabèze, Gabriel Thabut, Hilario Nunes, Vincent Cottin, Sylvain Marchand-Adam, Grégoire Prevot, Abdellatif Tazi, Jacques Cadranel, Herve Mal, Lidwine Wemeau-Stervinou, Anne Bergeron Lafaurie, Dominique Israel-Biet, Clement Picard, Martine Reynaud Gaubert, Stephane Jouneau, Jean-Marc Naccache, Julie Mankikian, Christelle Ménard, Jean-François Cordier, Dominique Valeyre, Marion Reocreux, Bernard Grandchamp, Patrick Revy, Caroline Kannengiesser, Bruno Crestani

Source: Eur Respir J 2016; 48: 1721-1731
Journal Issue: December
Disease area: Interstitial lung diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Raphael Borie, Laure Tabèze, Gabriel Thabut, Hilario Nunes, Vincent Cottin, Sylvain Marchand-Adam, Grégoire Prevot, Abdellatif Tazi, Jacques Cadranel, Herve Mal, Lidwine Wemeau-Stervinou, Anne Bergeron Lafaurie, Dominique Israel-Biet, Clement Picard, Martine Reynaud Gaubert, Stephane Jouneau, Jean-Marc Naccache, Julie Mankikian, Christelle Ménard, Jean-François Cordier, Dominique Valeyre, Marion Reocreux, Bernard Grandchamp, Patrick Revy, Caroline Kannengiesser, Bruno Crestani. Prevalence and characteristics of TERT and TERC mutations in suspected genetic pulmonary fibrosis. Eur Respir J 2016; 48: 1721-1731

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Heterozygous RTEL1 mutations are associated with familial pulmonary fibrosis
Source: Eur Respir J 2015; 46: 474-485
Year: 2015



Mutations in SFTPC, SFTPA2 and TERT explain 60% of familial pulmonary fibrosis and correlate to specific disease phenotypes
Source: Annual Congress 2011 - Genetic and molecular background in pulmonary fibrosis
Year: 2011

First heterozygous NOP10 mutation in familial pulmonary fibrosis
Source: Eur Respir J, 55 (6) 1902465; 10.1183/13993003.02465-2019
Year: 2020



Pulmonary fibrosis in non-mutation carriers of families with short telomere syndrome gene mutations.
Source: Virtual Congress 2021 – Genetics and translational aspects of idiopathic pulmonary fibrosis
Year: 2021



TERT/TERC mutations in a Greek cohort of suspected genetic pulmonary fibrosis patients
Source: International Congress 2018 – Idiopathic interstital pneumonias other than idiopathic pulmonary fibrosis (IPF)
Year: 2018

Telomere-Related Gene mutations in a Greek cohort of suspected monogenic pulmonary fibrosis patients
Source: Virtual Congress 2020 – Idiopathic pulmonary fibrosis and interstitial lung disease: progression, genes and more
Year: 2020


Novel rare genetic variants in idiopathic pulmonary fibrosis
Source: Eur Respir J, 56 (6) 2003252; 10.1183/13993003.03252-2020
Year: 2020



Combined pulmonary fibrosis and emphysema syndrome associated with ABCA3 mutations
Source: Eur Respir J 2014; 43: 638-641
Year: 2013


Regulator of telomere length 1 (RTEL1) mutations are associated with heterogeneous pulmonary and extra-pulmonary phenotypes
Source: Eur Respir J, 53 (2) 1800508; 10.1183/13993003.00508-2018
Year: 2019



Pulmonary fibrosis associated with TINF2 gene mutation: is somatic reversion required?
Source: Eur Respir J 2014; 44: 270-271
Year: 2014


Pulmonary fibrosis associated with TINF2 gene mutation: is somatic reversion required?
Source: Eur Respir J 2014; 44: 269-270
Year: 2014


Familial interstitial lung disease and ABCA3 gene Gly964Asp mutation
Source: Annual Congress 2010 - Pathogenesis of diffuse parenchymal lung disease
Year: 2010


First identified “severe” mutations and extended rearrangements in the CFTR gene in Russian cystic fibrosis patients
Source: Virtual Congress 2020 – Cystic fibrosis
Year: 2020


Phenotype characterisation of TBX4 mutation and deletion carriers with neonatal and paediatric pulmonary hypertension
Source: Eur Respir J, 54 (2) 1801965; 10.1183/13993003.01965-2018
Year: 2019



Clinical outcomes after lung transplantation for fibrosis in telomerase related genes mutation carriers
Source: International Congress 2019 – Lung transplantation: from basic science to clinical outcomes
Year: 2019


Echocardiography of pulmonary vascular function in asymptomatic carriers of BMPR2 mutations
Source: Eur Respir J 2012; 40: 1287-1289
Year: 2012


Novel idiopathic pulmonary fibrosis susceptibility variants revealed by deep sequencing
Source: ERJ Open Res, 5 (2) 00071-2019; 10.1183/23120541.00071-2019
Year: 2019



Telomeres revisited: RTEL1 variants in pulmonary fibrosis
Source: Eur Respir J 2015; 46: 312-314
Year: 2015